- Home
- Publications
- Publication Search
- Publication Details
Title
Metronomics chemotherapy: time for computational decision support
Authors
Keywords
Metronomics, Modeling and simulation, Vinorelbine, Lung cancer, Computational oncology
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 74, Issue 3, Pages 647-652
Publisher
Springer Nature
Online
2014-07-31
DOI
10.1007/s00280-014-2546-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression
- (2015) Chong-Sheng Chen et al. NEOPLASIA
- Metronomics: towards personalized chemotherapy?
- (2014) Nicolas André et al. Nature Reviews Clinical Oncology
- Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration
- (2014) Zvia Agur et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
- (2013) Evangelos Briasoulis et al. BMC CANCER
- A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens
- (2013) C. Faivre et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Low-dose metronomic chemotherapy: A systematic literature analysis
- (2013) K. Lien et al. EUROPEAN JOURNAL OF CANCER
- An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment
- (2013) Orazio Caffo et al. Expert Opinion on Drug Metabolism & Toxicology
- A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group
- (2013) Emmanouil Kontopodis et al. JOURNAL OF CHEMOTHERAPY
- Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia
- (2013) Neerav Shukla et al. PEDIATRIC BLOOD & CANCER
- Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
- (2012) Raffaele Addeo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Progress in Strategies for Dosage Regimen Individualization
- (2012) Hafedh Marouani et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma – A report from the Société Française des Cancers et leucémies de l’Enfant et de l’adolescent (SFCE)
- (2012) Véronique Minard-Colin et al. EUROPEAN JOURNAL OF CANCER
- Bayesian clinical trials in action
- (2012) J. Jack Lee et al. STATISTICS IN MEDICINE
- Phase I trial of metronomic oral vinorelbine in patients with advanced cancer
- (2011) Lakshmi Rajdev et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
- (2011) Zacharenia Saridaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC
- (2010) Athanasios G. Pallis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
- (2010) Raffaele Addeo et al. Clinical Breast Cancer
- Metronomic chemotherapy: Back to the future!
- (2010) N. André et al. DRUG NEWS & PERSPECTIVES
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer
- (2009) Robert S. Kerbel BREAST
- Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
- (2009) E. Briasoulis et al. CLINICAL CANCER RESEARCH
- Using Pharmacokinetic and Pharmacodynamic Modeling and Simulation to Evaluate Importance of Schedule in Topotecan Therapy for Pediatric Neuroblastoma
- (2008) J. C. Panetta et al. CLINICAL CANCER RESEARCH
- An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics
- (2008) C. Meille et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Mathematical modelling for the assessment of the effect of drug application delays in metronomic chemotherapy of cancer due to physiological constraints
- (2007) Abhik Mukherjee et al. BIOSYSTEMS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started